NPORT-EX 2 smallcap-nport.htm NPORT-EX

Investment Portfolio
        
(UNAUDITED) | 07.31.2020
        
CARILLON SCOUT SMALL CAP FUND
        
COMMON STOCKS - 99.7%
  
Shares
    
Value
  
Aerospace & defense - 1.5%
        
Kratos Defense & Security Solutions, Inc.*
    
245,981
    
$
4,430,118
  
Air freight & logistics - 0.9%
          
Forward Air Corp.
    
52,111
      
2,709,251
  
Auto components - 0.8%
          
Stoneridge, Inc.*
    
111,542
      
2,311,150
  
Automobiles - 1.8%
          
Thor Industries, Inc.
    
48,354
      
5,511,872
  
Banks - 0.7%
          
Hilltop Holdings, Inc.
    
112,781
      
2,195,846
  
Biotechnology - 3.8%
          
Eagle Pharmaceuticals, Inc.*
    
63,588
      
2,949,847
  
Halozyme Therapeutics, Inc.*
    
155,336
      
4,223,586
  
Insmed, Inc.*
    
166,228
      
4,341,875
  
Capital markets - 2.4%
          
Blucora, Inc.*
    
111,935
      
1,319,714
  
Cohen & Steers, Inc.
    
96,345
      
5,798,042
  
Chemicals - 1.6%
          
Balchem Corp.
    
47,278
      
4,740,092
  
Commercial services & supplies - 1.1%
          
Healthcare Services Group, Inc.
    
119,587
      
3,131,984
  
Construction & engineering - 0.9%
          
Dycom Industries, Inc.*
    
64,723
      
2,772,086
  
Consumer finance - 3.8%
          
Green Dot Corp., Class A*
    
54,398
      
2,757,435
  
LendingTree, Inc.*(a)
    
16,810
      
5,821,135
  
PRA Group, Inc.*
    
73,736
      
2,916,996
  
Electrical equipment - 1.4%
          
TPI Composites, Inc.*
    
167,427
      
4,282,783
  
Electronic equipment, instruments & components - 5.8%
          
ePlus, Inc.*
    
43,488
      
3,241,596
  
Fabrinet*
    
61,569
      
4,471,756
  
II-VI, Inc.*
    
114,978
      
5,831,684
  
Plexus Corp.*
    
53,313
      
3,960,623
  
Energy equipment & services - 0.3%
          
Core Laboratories N.V.
    
41,437
      
883,851
  
Equity real estate investment trusts (REITs) - 2.1%
          
CareTrust REIT, Inc.
    
121,793
      
2,194,710
  
QTS Realty Trust, Inc., Class A
    
57,869
      
4,163,674
  
Food & staples retailing - 1.2%
          
Performance Food Group Co.*
    
128,222
      
3,592,780
  

Health care equipment & supplies - 7.1%
        
Cantel Medical Corp.
    
48,458
      
2,289,641
  
ICU Medical, Inc.*
    
27,837
      
5,114,492
  
Integer Holdings Corp.*
    
54,807
      
3,604,656
  
Quidel Corp.*
    
31,295
      
8,839,899
  
Varex Imaging Corp.*
    
100,158
      
1,570,477
  
Health care providers & services - 9.8%
          
AdaptHealth Corp.*(a)
    
88,600
      
1,725,928
  
AMN Healthcare Services, Inc.*
    
96,663
      
5,310,665
  
BioTelemetry, Inc.*
    
105,311
      
4,482,036
  
HealthEquity, Inc.*
    
87,757
      
4,524,751
  
LHC Group, Inc.*
    
45,879
      
8,951,452
  
U.S. Physical Therapy, Inc.
    
53,959
      
4,481,835
  
Health care technology - 3.4%
          
HMS Holdings Corp.*
    
114,408
      
3,718,260
  
Omnicell, Inc.*
    
90,954
      
6,393,157
  
Hotels, restaurants & leisure - 1.7%
          
Cracker Barrel Old Country Store, Inc.
    
21,676
      
2,394,548
  
Lindblad Expeditions Holdings, Inc.*
    
162,026
      
1,174,688
  
The Cheesecake Factory, Inc.(a)
    
64,454
      
1,546,896
  
Household durables - 4.6%
          
Installed Building Products, Inc.*
    
66,510
      
5,261,606
  
iRobot Corp.*(a)
    
34,719
      
2,523,724
  
LGI Homes, Inc.*
    
53,763
      
6,134,896
  
Insurance - 0.7%
          
CNO Financial Group, Inc.
    
139,246
      
2,102,615
  
Internet & direct marketing retail - 0.7%
          
PetMed Express, Inc.(a)
    
66,751
      
2,082,631
  
IT services - 1.1%
          
Virtusa Corp.*
    
79,627
      
3,232,856
  
Life sciences tools & services - 7.7%
          
Bruker Corp.
    
134,913
      
6,019,818
  
Medpace Holdings, Inc.*
    
60,423
      
7,211,485
  
NeoGenomics, Inc.*
    
114,406
      
4,373,741
  
PRA Health Sciences, Inc.*
    
51,498
      
5,487,627
  
Machinery - 5.0%
          
Albany International Corp., Class A
    
59,254
      
2,848,932
  
Chart Industries, Inc.*
    
85,478
      
5,857,807
  
Proto Labs, Inc.*
    
52,045
      
6,251,646
  
Metals & mining - 0.2%
          
Carpenter Technology Corp.
    
31,380
      
701,657
  
Pharmaceuticals - 1.0%
          
Supernus Pharmaceuticals, Inc.*
    
135,806
      
3,023,721
  
Professional services - 1.6%
          
Insperity, Inc.
    
72,650
      
4,857,379
  

Semiconductors & semiconductor equipment - 8.6%
        
Ambarella, Inc.*
    
60,667
      
2,747,002
  
Entegris, Inc.
    
83,302
      
5,990,247
  
Impinj, Inc.*
    
73,956
      
1,745,361
  
Inphi Corp.*
    
41,668
      
5,444,341
  
Power Integrations, Inc.
    
35,523
      
4,334,872
  
Semtech Corp.*
    
99,926
      
5,568,876
  
Software - 11.4%
          
Envestnet, Inc.*
    
65,692
      
5,334,191
  
J2 Global, Inc.*
    
62,121
      
3,523,503
  
Pegasystems, Inc.
    
78,180
      
9,138,460
  
Qualys, Inc.*
    
41,030
      
5,066,384
  
The Descartes Systems Group, Inc.*
    
100,046
      
5,635,591
  
Upland Software, Inc.*
    
83,259
      
2,865,775
  
Verint Systems, Inc.*
    
59,199
      
2,657,443
  
Specialty retail - 1.6%
          
Monro, Inc.
    
83,928
      
4,725,146
  
Textiles, apparel & luxury goods - 0.3%
          
G-III Apparel Group Ltd.*
    
84,358
      
834,301
  
Thrifts & mortgage finance - 0.8%
          
Axos Financial, Inc.*
    
105,116
      
2,355,650
  
Trading companies & distributors - 2.3%
          
Applied Industrial Technologies, Inc.
    
57,802
      
3,648,462
  
Systemax, Inc.
    
140,438
      
3,147,216
  
Total common stocks (cost $185,997,330)
      
299,412,829
  
                 
MONEY MARKET FUNDS - 3.2%
          
First American Government Obligations Fund - Class X, 0.08%#
    
9,655,480
      
9,655,480
  
Total money market funds (cost $9,655,480)
      
9,655,480
  
Total investment portfolio (cost $195,652,810) - 102.9%
      
309,068,309
  
Liabilities in excess of other assets - (2.9)%
      
(8,646,001
)
Total net assets - 100.0%
    
$
300,422,308
  

* Non-income producing security
      
(a) All or a portion of this security was on loan as of the date of this report. The total market value of loaned securities was $9,217,633 or 3.1% of net assets as of the date of this report.
 # Annualized seven-day yield as of the date of this report. Investment made with cash collateral received for securities on loan.
 

Fair value measurements | The Fund utilizes a three-level hierarchy of inputs to establish a classification of fair value measurements. The three levels are defined as:
Level 1—Valuations based on unadjusted quoted prices for identical securities in active markets;
Level 2—Valuations based on inputs other than quoted prices that are observable, either directly or indirectly, including inputs in markets that are not considered active; and
Level 3—Valuations based on inputs that are unobservable and significant to the fair value measurement, and may include the Valuation Committee’s own assumptions on determining fair value of investments.
         
Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments and is affected by various factors such as the type of investment and the volume and/or level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Valuation Committee, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the valuation date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy. Investments falling into the Level 3 category may be classified as such due to a lack of market transparency and corroboration to support the quoted prices. Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Valuation Committee. Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable entity data.
         
All investments are categorized as Level 1 as of the date of this report.
         
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual report.
         
The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of Morgan Stanley Capital International, Inc. (“MSCI”) and Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bancorp Fund Services, LLC.